Citations

Clear

3485 citation(s) found for "Sy, Sarah".

BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation
Ghosh, Toshi, Greipp, Patricia T. , Knutson, Darlene L., Kloft‐Nelson, Sara M. , Jenkins, Sarah M. , Mounajjed, Taofic, Said, Samar M. , Sessa, Fausto , Naini, Bita V. , Zhang, Lizhi , Kerr, Sarah E. , Graham, Rondell P. , Knutson, Darlene, Kloft-Nelson, Sara, Graham, Rondell P , Greipp, Patricia T , Rosa, Stefano La , Vanoli, Alessandro , Bellizzi, Andrew M.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | October 9, 2021 | Volume: 146 | Issue: 7 | Pages: 840-845

10.5858/arpa.2020-0739-oa | PMID 34614142 Get It

Context.— Comprehensive genomic profiling has demonstrated that approximately 20% of pancreatic carcinomas with acinar differentiation harbor potentially targetable BRAF fusions that activate the MAPK pathway. Objectives.— To validate the above finding by BRAF break-apart fluorescence in situ hybridization (FISH) in a large series of pure acinar cell carcinomas (ACCs), evaluate tumors for the presence of BRAF V600E mutations, and compare clinicopathologic features of tumors with BRAF rearrangements with those without. Design.— Thirty cases of pure ACC and 6 cases of mixed acinar-neuroendocrine carcinoma (ACC-NEC) were retrieved. A break-apart FISH probe was used to detect BRAF rearrangements. Immunohistochemistry for BRAF V600E was performed. Results.— BRAF rearrangements by FISH were found in 6 of 36 cases (17%), 5 of which were pure ACC and 1 was a mixed ACC-NEC. Follow-up was available in 29 of 36 cases (81%). The median survival was 22 months for BRAF-rearranged cases and 16 months for BRAF-intact cases; the 2-year overall survival was 50% for BRAF-rearranged cases and 35% for BRAF-intact cases. No significant clinicopathologic differences were identified in cases with BRAF rearrangement compared with those without BRAF rearrangement. BRAF V600E mutation was identified in 2 of 34 cases (6%), both of which were pure ACC and were BRAF-intact by FISH. Conclusions.— This study supports the finding that BRAF rearrangements are present in approximately 20% of cases and identified BRAF V600E mutations in approximately 5% of cases. These cases may benefit from targeted therapy.
Masks, Empathy, and a Pediatric Cancer Diagnosis During COVID-19
McCarthy, Sarah , Schiltz, Brenda , McCarthy, Sarah R. , McCarthy, Sarah R Brand, McCarthy, Sarah R , McCarthy, Sarah R.

Mayo Clinic

Pediatrics | October 7, 2021 | Volume: 148 | Issue: 5 | Pages: No page available

10.1542/peds.2021-051696 | PMID 34620726 Get It

Definitive Diagnostic Evaluation of the Child With Arterial Ischemic Stroke and Approaches to Secondary Stroke Prevention
Lee, Sarah , Wasserman, Bruce A. , Heit, Jeremy J. , Negrotto, Matías , Abruzzo, Todd , Abruzzo, Todd A, Heit, Jeremy J , Muthusami, Prakash , Chandra, Ronil Vikesh , Hui, Ferdinand

Mayo Clinic

Topics in Magnetic Resonance Imaging | October 7, 2021 | Volume: 30 | Issue: 5 | Pages: 225-230

10.1097/rmr.0000000000000272 | PMID 34613945 Get It

Abstract In children with arterial ischemic stroke (AIS), the definitive diagnosis of stroke subtype and confirmation of stroke etiology is necessary to mitigate stroke morbidity and prevent recurrent stroke. The common causes of AIS in children are sharply differentiated from the common causes of adult AIS. A comprehensive, structured diagnostic approach will identify the etiology of stroke in most children. Adequate diagnostic evaluation relies on advanced brain imaging and vascular imaging studies. A variety of medical and surgical secondary stroke prevention strategies directed at the underlying cause of stroke are available. This review aims to outline strategies for definitive diagnosis and secondary stroke prevention in children with AIS, emphasizing the critical role of neuroimaging.
Initial Diagnostic Evaluation of the Child With Suspected Arterial Ischemic Stroke
Negrotto, Matías , Wasserman, Bruce A. , Lee, Sarah , Heit, Jeremy J. , Abruzzo, Todd , Abruzzo, Todd A, Heit, Jeremy J , Muthusami, Prakash , Chandra, Ronil Vikesh , Hui, Ferdinand

Mayo Clinic

Topics in Magnetic Resonance Imaging | October 7, 2021 | Volume: 30 | Issue: 5 | Pages: 211-223

10.1097/rmr.0000000000000276 | PMID 34613944 Get It

Abstract Numerous factors make the initial diagnostic evaluation of children with suspected arterial ischemic stroke (AIS) a relatively unsettling challenge, even for the experienced stroke specialist. The low frequency of pediatric AIS, diversity of unique age-oriented stroke phenotypes, and unconventional approaches required for diagnosis and treatment all contribute difficulty to the process. This review aims to outline important features that differentiate pediatric AIS from adult AIS and provide practical strategies that will assist the stroke specialist with diagnostic decision making in the initial phase of care.
Reperfusion Therapies for Children With Arterial Ischemic Stroke
Heit, Jeremy J. , Negrotto, Matías , Lee, Sarah , Wasserman, Bruce A. , Abruzzo, Todd , Abruzzo, Todd A, Heit, Jeremy J , Muthusami, Prakash , Chandra, Ronil Vikesh , Hui, Ferdinand

Mayo Clinic

Topics in Magnetic Resonance Imaging | October 7, 2021 | Volume: 30 | Issue: 5 | Pages: 231-243

10.1097/rmr.0000000000000273 | PMID 34613946 Get It

Abstract Modern hyperacute reperfusion therapies including intravenous thrombolysis and mechanical thrombectomy have transformed the management of arterial ischemic stroke (AIS) in adults. Multiple randomized clinical trials have demonstrated that these therapies enable remarkable improvements in clinical outcome for properly selected patients with AIS. Because pediatric patients were excluded from predicate clinical trials, there is a conspicuous lack of data to guide selection of therapies and inform age-adjusted and pathology-oriented treatment modifications for children. Specifically, technical guidance concerning treatment eligibility, drug dosing, and device implementation is lacking. This review aims to outline important features that differentiate pediatric AIS from adult AIS and provide practical strategies that will assist the stroke specialist with therapeutic decision making.
Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States
Solomon, Andrew , Kaisey, Marwa , Krieger, Stephen, Chahin, Salim , Weinstein, Sarah M. , Weinstein, Sarah M , Naismith, Robert T. , Shinohara, Russell Taki , Weinshenker, Brian G.

Mayo Clinic

Multiple Sclerosis Journal | October 6, 2021 | Volume: 28 | Issue: 8 | Pages: 1248-1256

10.1177/13524585211048401 | PMID 34612110 Get It

Background: Few studies have addressed the results of educational efforts concerning proper use of McDonald criteria (MC) revisions outside multiple sclerosis (MS) subspecialty centers. Neurology residents and MS subspecialist neurologists demonstrated knowledge gaps for core elements of the MC in a recent prior study. Objective: To assess comprehension and application of MC core elements by non-MS specialist neurologists in the United States who routinely diagnose MS. Methods: Through a cross-sectional study design, a previously developed survey instrument was distributed online. Results: A total of 222 neurologists completed the study survey. Syndromes atypical for MS were frequently incorrectly considered “typical” MS presentations. Fourteen percent correctly identified definitions of both “periventricular” and “juxtacortical” lesions and 2% correctly applied these terms to 9/9 images. Twenty-four percent correctly identified all four central nervous system (CNS) regions for satisfaction of magnetic resonance imaging (MRI) dissemination in space. In two presented cases, 61% and 71% correctly identified dissemination in time (DIT) was not fulfilled, and 85% and 86% subsequently accepted nonspecific historical symptoms without objective evidence for DIT fulfillment. Conclusion: The high rate of knowledge deficiencies and application errors of core elements of the MC demonstrated by participants in this study raise pressing questions concerning adequacy of dissemination and educational efforts upon publication of revisions to MC.
Resting State Functional Magnetic Resonance Imaging Elucidates Neurotransmitter Deficiency in Autism Spectrum Disorder
McCarty, Patrick J. , Sussman, Bethany L. , Wyckoff, Sarah N. , Jensen, Amanda , Bunch, Raymond, Boerwinkle, Varina L. , Frye, Richard E. , Pines, Andrew R. , Sussman, Bethany L , Wyckoff, Sarah N , Frye, Richard E , Jensen, Amanda

Mayo Clinic

Journal of Personalized Medicine | September 28, 2021 | Volume: 11 | Issue: 10 | Pages: 969

10.3390/jpm11100969 | PMID 34683111 Get It

Resting-state functional magnetic resonance imaging provides dynamic insight into the functional organization of the brains’ intrinsic activity at rest. The emergence of resting-state functional magnetic resonance imaging in both the clinical and research settings may be attributed to recent advancements in statistical techniques, non-invasiveness and enhanced spatiotemporal resolution compared to other neuroimaging modalities, and the capability to identify and characterize deep brain structures and networks. In this report we describe a 16-year-old female patient with autism spectrum disorder who underwent resting-state functional magnetic resonance imaging due to late regression. Imaging revealed deactivated networks in deep brain structures involved in monoamine synthesis. Monoamine neurotransmitter deficits were confirmed by cerebrospinal fluid analysis. This case suggests that resting-state functional magnetic resonance imaging may have clinical utility as a non-invasive biomarker of central nervous system neurochemical alterations by measuring the function of neurotransmitter-driven networks. Use of this technology can accelerate and increase the accuracy of selecting appropriate therapeutic agents for patients with neurological and neurodevelopmental disorders.
Current directions in tau research: Highlights from Tau 2020
Sexton, Claire E. , Snyder, Heather M. , Boxer, Adam L. , Brannelly, Patrick , Brion, Jean‐Pierre , Buée, Luc , Cacace, Angela , Chételat, Gaël , Citron, Martin , DeVos, Sarah L. , Diaz, Kristophe , Feldman, Howard , Frost, Bess , Goate, Alison , Gold, Michael , Johnson, Keith A. , Kerwin, Diana , Mummery, Catherine J. , Mutamba, James, Quiroz, Yakeel T. , Rabinovici, Gil D. , Rommel, Amy, Shulman, Melanie , Toledo‐Sherman, Leticia , Weninger, Stacie, Wildsmith, Kristin R., Worley, Susan, Carrillo, María C. , Sexton, Claire , Patterson, Marc C. , Rabinovici, Gil D , Feldman, Howard H , Goate, Alison M , Beher, Dirk , Hyman, Bradley T. , Karch, Celeste M. , Koroshetz, Walter J. , Litvan, Irene , Morris, Huw R.

Mayo Clinic

Alzheimer's & Dementia | September 28, 2021 | Volume: 18 | Issue: 5 | Pages: 988-1007

10.1002/alz.12452 | PMID 34581500 Get It

AbstractStudies supporting a strong association between tau deposition and neuronal loss, neurodegeneration, and cognitive decline have heightened the allure of tau and tau‐related mechanisms as therapeutic targets. In February 2020, leading tau experts from around the world convened for the first‐ever Tau2020 Global Conference in Washington, DC, co‐organized and cosponsored by the Rainwater Charitable Foundation, the Alzheimer's Association, and CurePSP. Representing academia, industry, government, and the philanthropic sector, presenters and attendees discussed recent advances and current directions in tau research. The meeting provided a unique opportunity to move tau research forward by fostering global partnerships among academia, industry, and other stakeholders and by providing support for new drug discovery programs, groundbreaking research, and emerging tau researchers. The meeting also provided an opportunity for experts to present critical research‐advancing tools and insights that are now rapidly accelerating the pace of tau research.
Automatic wide complex tachycardia differentiation using mathematically synthesized vectorcardiogram signals
Kashou, Anthony H. , LoCoco, Sarah , McGill, Trevon, Evenson, Christopher M., Deshmukh, Abhishek , Hodge, David O. , Cooper, Daniel , Sodhi, Sandeep , Cuculich, Phillip S. , Asirvatham, Samuel J. , May, Adam M. , McGill, Trevon D, May, Adam M , Asirvatham, Samuel J , Noseworthy, Peter A. , DeSimone, Christopher V.

Mayo Clinic

Annals of Noninvasive Electrocardiology | September 25, 2021 | Volume: 27 | Issue: 1 | Pages: No page available

10.1111/anec.12890 | PMID 34562325 Get It

AbstractBackgroundAutomated wide complex tachycardia (WCT) differentiation into ventricular tachycardia (VT) and supraventricular wide complex tachycardia (SWCT) may be accomplished using novel calculations that quantify the extent of mean electrical vector changes between the WCT and baseline electrocardiogram (ECG). At present, it is unknown whether quantifying mean electrical vector changes within three orthogonal vectorcardiogram (VCG) leads (X, Y, and Z leads) can improve automated VT and SWCT classification.MethodsA derivation cohort of paired WCT and baseline ECGs was used to derive five logistic regression models: (i) one novel WCT differentiation model (i.e., VCG Model), (ii) three previously developed WCT differentiation models (i.e., WCT Formula, VT Prediction Model, and WCT Formula II), and (iii) one “all‐inclusive” model (i.e., Hybrid Model). A separate validation cohort of paired WCT and baseline ECGs was used to trial and compare each model's performance.ResultsThe VCG Model, composed of WCT QRS duration, baseline QRS duration, absolute change in QRS duration, X‐lead QRS amplitude change, Y‐lead QRS amplitude change, and Z‐lead QRS amplitude change, demonstrated effective WCT differentiation (area under the curve [AUC] 0.94) for the derivation cohort. For the validation cohort, the diagnostic performance of the VCG Model (AUC 0.94) was similar to that achieved by the WCT Formula (AUC 0.95), VT Prediction Model (AUC 0.91), WCT Formula II (AUC 0.94), and Hybrid Model (AUC 0.95).ConclusionCustom calculations derived from mathematically synthesized VCG signals may be used to formulate an effective means to differentiate WCTs automatically.
Titanium Cervical Cage Subsidence: Postoperative Computed Tomography Analysis Defining Incidence and Associated Risk Factors
Pinter, Zachariah W. , Reed, Ryder, Townsley, Sarah E., Mikula, Anthony L. , Dittman, Lauren E. , Xiong, Ashley , Skjaerlund, Jonathan, Michalopoulos, Giorgos D. , Currier, Bradford L. , Fogelson, Jeremy L. , Freedman, Brett A. , Bydon, Mohamad , Kepler, Christopher K. , Wagner, Scott C. , Elder, Benjamin D. , Sebastian, Arjun S. , Dittman, Lauren, Freedman, Brett A , Bydon, Mohamad , Michalopoulos, Giorgos , Nassr, Ahmad

Mayo Clinic

Global Spine Journal | September 24, 2021 | Volume: 13 | Issue: 7 | Pages: 1703-1715

10.1177/21925682211046897 | PMID 34558320 Get It

Study Design Retrospective cohort study Objective Substantial variability in both the measurement and classification of subsidence limits the strength of conclusions that can be drawn from previous studies. The purpose of this study was to precisely characterize patterns of cervical cage subsidence utilizing computed tomography (CT) scans, determine risk factors for cervical cage subsidence, and investigate the impact of subsidence on pseudarthrosis rates. Methods We performed a retrospective review of patients who underwent one- to three-levels of anterior cervical discectomy and fusion (ACDF) utilizing titanium interbodies with anterior plating between the years 2018 and 2020. Subsidence measurements were performed by two independent reviewers on CT scans obtained 6 months postoperatively. Subsidence was then classified as mild if subsidence into the inferior and superior endplate were both ≤2 mm, moderate if the worst subsidence into the inferior or superior endplate was between 2 to 4 mm, or severe if the worst subsidence into the inferior or superior endplate was ≥4 mm. Results A total of 51 patients (100 levels) were included in this study. A total of 48 levels demonstrated mild subsidence (≤2 mm), 38 demonstrated moderate subsidence (2-4 mm), and 14 demonstrated severe subsidence (≥4 mm). Risk factors for severe subsidence included male gender, multilevel constructs, greater mean vertebral height loss, increased cage height, lower Taillard index, and lower screw tip to vertebral body height ratio. Severe subsidence was not associated with an increased rate of pseudarthrosis. Conclusion Following ACDF with titanium cervical cages, subsidence is an anticipated postoperative occurrence and is not associated with an increased risk of pseudarthrosis.